PRX

Pharmacutical (PRX)

Pharmaceutical Companies

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:PRX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2015/08/10	22:10	Dow Jones News	Endo International Beats Revenue, Earnings Targets	NYSE:PRX	Pharmaceutical Companies
2015/05/26	23:19	PR Newswire (US)	Par Specialty Pharmaceuticals Launches Cortisporin®-TC Otic Suspension	NYSE:PRX	Pharmaceutical Companies
2015/05/19	05:09	Dow Jones News	Stocks Gain; Dow, S&P 500 Flirt With Records	NYSE:PRX	Pharmaceutical Companies
2015/05/19	02:50	Dow Jones News	Stocks Gain; Dow, S&P 500 Flirt With Records	NYSE:PRX	Pharmaceutical Companies
2015/05/19	01:18	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 4th Update	NYSE:PRX	Pharmaceutical Companies
2015/05/19	00:53	Dow Jones News	U.S. Stocks Waver After Dow Touches Record	NYSE:PRX	Pharmaceutical Companies
2015/05/19	00:05	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd Update	NYSE:PRX	Pharmaceutical Companies
2015/05/18	23:37	Dow Jones News	U.S. Stocks Edge Higher; Dow Hits Record	NYSE:PRX	Pharmaceutical Companies
2015/05/18	22:20	Dow Jones News	Endo to Buy Par Pharma	NYSE:PRX	Pharmaceutical Companies
2015/05/18	21:53	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd Update	NYSE:PRX	Pharmaceutical Companies
2015/05/18	21:50	Dow Jones News	U.S. Stock Futures Edge Lower	NYSE:PRX	Pharmaceutical Companies
2015/05/18	20:44	Dow Jones News	Endo to Buy Generics Maker Par Pharma for About $8 Billion -- Update	NYSE:PRX	Pharmaceutical Companies
2014/03/19	05:32	Edgar (US Regulatory)	Annual Report (10-k)	NYSE:PRX	Pharmaceutical Companies
2014/02/21	04:45	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:PRX	Pharmaceutical Companies
2014/02/20	05:08	Edgar (US Regulatory)	Definitive Materials Filed by Investment Companies. (497)	NYSE:PRX	Pharmaceutical Companies
2014/02/20	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:PRX	Pharmaceutical Companies
2013/11/12	22:06	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:PRX	Pharmaceutical Companies
2013/08/28	19:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NYSE:PRX	Pharmaceutical Companies
2013/08/28	19:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NYSE:PRX	Pharmaceutical Companies
2013/08/28	00:36	Edgar (US Regulatory)	Semi-annual Report (management Company) (nsar-a)	NYSE:PRX	Pharmaceutical Companies
2013/08/28	00:36	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NYSE:PRX	Pharmaceutical Companies
2013/08/15	21:13	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NYSE:PRX	Pharmaceutical Companies
2013/02/12	01:55	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:PRX	Pharmaceutical Companies
2012/10/16	21:58	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	NYSE:PRX	Pharmaceutical Companies
2012/10/12	21:30	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	NYSE:PRX	Pharmaceutical Companies
2012/10/10	23:59	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NYSE:PRX	Pharmaceutical Companies
2012/10/10	00:03	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NYSE:PRX	Pharmaceutical Companies
2012/10/10	00:02	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NYSE:PRX	Pharmaceutical Companies
2012/10/10	00:01	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NYSE:PRX	Pharmaceutical Companies
2012/10/10	00:00	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NYSE:PRX	Pharmaceutical Companies